201 related articles for article (PubMed ID: 32830472)
1. Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea.
Noh JY; Seo YB; Yoon JG; Seong H; Hyun H; Lee J; Lee N; Jung S; Park MJ; Song W; Yoon J; Lim CS; Ryou J; Lee JY; Kim SS; Cheong HJ; Kim WJ; Yoon SY; Song JY
J Korean Med Sci; 2020 Aug; 35(33):e311. PubMed ID: 32830472
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
[TBL] [Abstract][Full Text] [Related]
3. Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020.
Sutton M; Cieslak P; Linder M
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(32):1100-1101. PubMed ID: 32790658
[No Abstract] [Full Text] [Related]
4. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I
Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.
Sood N; Simon P; Ebner P; Eichner D; Reynolds J; Bendavid E; Bhattacharya J
JAMA; 2020 Jun; 323(23):2425-2427. PubMed ID: 32421144
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil.
Amorim Filho L; Szwarcwald CL; Mateos SOG; Leon ACMP; Medronho RA; Veloso VG; Lopes JIF; Porto LCMS; Chieppe A; Werneck GL;
Rev Saude Publica; 2020; 54():69. PubMed ID: 32638883
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area.
Moscola J; Sembajwe G; Jarrett M; Farber B; Chang T; McGinn T; Davidson KW;
JAMA; 2020 Sep; 324(9):893-895. PubMed ID: 32780804
[TBL] [Abstract][Full Text] [Related]
8. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
Bryan A; Pepper G; Wener MH; Fink SL; Morishima C; Chaudhary A; Jerome KR; Mathias PC; Greninger AL
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32381641
[TBL] [Abstract][Full Text] [Related]
9. Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil.
Silveira MF; Barros AJD; Horta BL; Pellanda LC; Victora GD; Dellagostin OA; Struchiner CJ; Burattini MN; Valim ARM; Berlezi EM; Mesa JM; Ikeda MLR; Mesenburg MA; Mantesso M; Dall'Agnol MM; Bittencourt RA; Hartwig FP; Menezes AMB; Barros FC; Hallal PC; Victora CG
Nat Med; 2020 Aug; 26(8):1196-1199. PubMed ID: 32641783
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
Petersen MS; Strøm M; Christiansen DH; Fjallsbak JP; Eliasen EH; Johansen M; Veyhe AS; Kristiansen MF; Gaini S; Møller LF; Steig B; Weihe P
Emerg Infect Dis; 2020 Nov; 26(11):2761-2763. PubMed ID: 32726200
[TBL] [Abstract][Full Text] [Related]
11. Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020.
Bogogiannidou Z; Vontas A; Dadouli K; Kyritsi MA; Soteriades S; Nikoulis DJ; Mouchtouri VΑ; Koureas M; Kazakos EI; Spanos EG; Gioula G; Ntzani EE; Eleftheriou AA; Vatopoulos A; Petinaki E; Papaevangelou V; Speletas M; Tsiodras S; Hadjichristodoulou C
Euro Surveill; 2020 Aug; 25(31):. PubMed ID: 32762796
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
[TBL] [Abstract][Full Text] [Related]
14. IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea.
Song SK; Lee DH; Nam JH; Kim KT; Do JS; Kang DW; Kim SG; Cho MR
J Korean Med Sci; 2020 Jul; 35(29):e269. PubMed ID: 32715672
[TBL] [Abstract][Full Text] [Related]
15. Operation and Management of Seoul Metropolitan City Community Treatment Center for Mild Condition COVID-19 Patients.
Lee SY; Song KJ; Lim CS; Kim BG; Chai YJ; Lee JK; Kim SH; Lim HJ
J Korean Med Sci; 2020 Oct; 35(40):e367. PubMed ID: 33075858
[TBL] [Abstract][Full Text] [Related]
16. Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020.
Hallowell BD; Carlson CM; Jacobs JR; Pomeroy M; Steinberg J; Tenforde MW; McDonald E; Foster L; Feldstein LR; Rolfes MA; Haynes A; Abedi GR; Odongo GS; Saruwatari K; Rider EC; Douville G; Bhakta N; Maniatis P; Lindstrom S; Thornburg NJ; Lu X; Whitaker BL; Kamili S; Sakthivel SK; Wang L; Malapati L; Murray JR; Lynch B; Cetron M; Brown C; Roohi S; Rotz L; Borntrager D; Ishii K; Moser K; Rasheed M; Freeman B; Lester S; Corbett KS; Abiona OM; Hutchinson GB; Graham BS; Pesik N; Mahon B; Braden C; Behravesh CB; Stewart R; Knight N; Hall AJ; Killerby ME
Emerg Infect Dis; 2020 Sep; 26(9):1998-2004. PubMed ID: 32620182
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS
J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833
[TBL] [Abstract][Full Text] [Related]
18. [Screening of Mothers in a COVID-19 Low-Prevalence Region: Determination of SARS-CoV-2 Antibodies in 401 Mothers from Rostock by ELISA and Confirmation by Immunofluorescence].
Reisinger EC; von Possel R; Warnke P; Geerdes-Fenge HF; Hemmer CJ; Pfefferle S; Löbermann M; Littmann M; Emmerich P
Dtsch Med Wochenschr; 2020 Aug; 145(17):e96-e100. PubMed ID: 32572869
[TBL] [Abstract][Full Text] [Related]
19. National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance.
Kumar MS; Bhatnagar T; Manickam P; Kumar VS; Rade K; Shah N; Kant S; Babu GR; Zodpey S; Girish Kumar CP; Vivian Thangaraj JW; Chatterjee P; Kanungo S; Pandey RM; Murhekar M; Singh SK; Sarkar S; Muliyi JP; Gangakhedkar RR; Reddy DCS
Indian J Med Res; 2020 May; 151(5):419-423. PubMed ID: 32611913
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study).
Mesnil M; Joubel K; Yavchitz A; Miklaszewski N; Devys JM
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):595-596. PubMed ID: 32861816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
